These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28742895)

  • 1. Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing.
    Knowles JW; Rader DJ; Khoury MJ
    JAMA; 2017 Jul; 318(4):381-382. PubMed ID: 28742895
    [No Abstract]   [Full Text] [Related]  

  • 2. Lessening the Burden of Familial Hypercholesterolemia Using Health Information Technology.
    Safarova MS; Kullo IJ
    Circ Res; 2018 Jan; 122(1):26-27. PubMed ID: 29301842
    [No Abstract]   [Full Text] [Related]  

  • 3. [Genetic screening for a pedigree of familial hypercholesterolemia].
    Zhu F; Zhong YC; Wang C; Zhang FX; Wang M; Dong SL; Wang X; Cheng X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Feb; 50(2):185-188. PubMed ID: 35172466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening for familial hypercholesterolemia].
    Cariou B; Krempf M
    Rev Prat; 2011 Oct; 61(8):1106-7. PubMed ID: 22135978
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of a motivational interviewing genetic counseling intervention to increase cascade cholesterol screening in families of children with familial hypercholesterolemia.
    Kruger V; Redlinger-Grosse K; Walters ST; Ash E; Cragun D; McCarthy Veach P; Zierhut HA
    J Genet Couns; 2019 Oct; 28(5):1059-1064. PubMed ID: 31273864
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening.
    Leren TP; Finborud TH; Manshaus TE; Ose L; Berge KE
    Community Genet; 2008; 11(1):26-35. PubMed ID: 18196915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cascade screening for familial hypercholesterolemia: Practical consequences.
    Louter L; Defesche J; Roeters van Lennep J
    Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia.
    McGowan MP; Hosseini Dehkordi SH; Moriarty PM; Duell PB
    J Am Heart Assoc; 2019 Dec; 8(24):e013225. PubMed ID: 31838973
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic testing of familial hypercholesterolemia in a real clinical setting.
    Vohnout B; Gabcova D; Huckova M; Klimes I; Gasperikova D; Raslova K
    Wien Klin Wochenschr; 2016 Dec; 128(23-24):916-921. PubMed ID: 27542166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cascade genetic screening for familial hypercholesterolemia.
    Leren TP
    Clin Genet; 2004 Dec; 66(6):483-7. PubMed ID: 15521974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Hypercholesterolemia: A Reportable Disorder.
    Kullo IJ
    Circulation; 2020 Nov; 142(21):1999-2001. PubMed ID: 33226870
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of registries and genetic databases in familial hypercholesterolemia.
    Kindt I; Mata P; Knowles JW
    Curr Opin Lipidol; 2017 Apr; 28(2):152-160. PubMed ID: 28169870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-guided diagnosis in familial hypercholesterolemia: clinical management and concerns.
    Hopkins PN; Lane SR
    Curr Opin Lipidol; 2017 Apr; 28(2):144-151. PubMed ID: 28157722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic screening and treatment in familial hypercholesterolemia].
    Leren TP; Tonstad S; Ose L
    Tidsskr Nor Laegeforen; 2001 May; 121(13):1635-6. PubMed ID: 11446055
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of Family Recruitment in a Program of Genetic Cascade Screening for Familial Hypercholesterolemia.
    Izar MCO; Fonseca FAH
    Arq Bras Cardiol; 2018 Oct; 111(4):585-586. PubMed ID: 30365680
    [No Abstract]   [Full Text] [Related]  

  • 16. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia.
    Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D
    J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hypercholesterolemia--epidemiology, diagnosis, and screening.
    Singh S; Bittner V
    Curr Atheroscler Rep; 2015; 17(2):482. PubMed ID: 25612857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are Genetic Tests for Atherosclerosis Ready for Routine Clinical Use?
    Paynter NP; Ridker PM; Chasman DI
    Circ Res; 2016 Feb; 118(4):607-19. PubMed ID: 26892961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Lipoprotein(a) and Its Implications for Familial Hypercholesterolemia Diagnosis, Prognosis, and Family Screening.
    Santos RD
    J Clin Endocrinol Metab; 2024 Jun; 109(7):e1544-e1545. PubMed ID: 38108434
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholesterol and family history: when genetics matters.
    Vengoechea J; McKelvey KD
    J Ark Med Soc; 2015 Feb; 111(9):184-6. PubMed ID: 25993767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.